Back
Leap Therapeutics Stock Predictions

Marketing's AI Disruption Is Now Secure Your Stake Today!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
11
LPTX
Leap Therapeutics
Last Price:
$0.29
Seasonality Move:
-4.17%
7 Day Trial
ALL ACCESS PASS
$
7

Final Days: Should You Invest in This AI Startup Now?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.Leap Therapeutics Stock Forecast
-
Is Leap Therapeutics Stock Undervalued?The current Leap Therapeutics [LPTX] share price is $0.31. The Score for LPTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
LPTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Leap Therapeutics Stock Go Up Next Year?
Data Unavailable
Leap Therapeutics Stock Rating
Data Unavailable
Leap Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
leaptx.com
52-Week Data
52-Week High:
4.79
52-Week Low:
0.28
Prediction Charts
Market Cap:
12.6M
Price in USD:
0.31
Volume:
902.2K
Beta:
0.71
Technical Analysis
SMA50:
0.68
SMA100:
1.86
SMA200:
2.18
52-Wk Change:
-88.53%
Stock Predictions
-
Is Leap Therapeutics stock public?Yes, Leap Therapeutics is a publicly traded company.
-
What is the Leap Therapeutics stock quote today?The Leap Therapeutics stock price is 0.31 USD today.
-
How to buy Leap Therapeutics stock online?You can buy Leap Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-12 | 0.40 | 0.40 | 0.42 | 0.39 |
Mar-13 | 0.40 | 0.39 | 0.42 | 0.39 |
Mar-14 | 0.40 | 0.40 | 0.42 | 0.39 |
Mar-17 | 0.41 | 0.42 | 0.45 | 0.41 |
Mar-18 | 0.43 | 0.41 | 0.43 | 0.41 |
Mar-19 | 0.41 | 0.42 | 0.44 | 0.41 |
Mar-20 | 0.42 | 0.41 | 0.44 | 0.41 |
Mar-21 | 0.41 | 0.40 | 0.41 | 0.39 |
Mar-24 | 0.41 | 0.39 | 0.41 | 0.39 |
Mar-25 | 0.40 | 0.39 | 0.42 | 0.39 |
Mar-26 | 0.46 | 0.45 | 0.65 | 0.41 |
Mar-27 | 0.41 | 0.36 | 0.42 | 0.36 |
Mar-28 | 0.34 | 0.32 | 0.35 | 0.31 |
Mar-31 | 0.31 | 0.31 | 0.33 | 0.28 |
Leap Therapeutics Earnings
Data Unavailable
Leap Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.39 per share.
* Leap Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.